(주)와이바이오로직스

{
  "address": "대전광역시 유성구",
  "ceo_name": "박영우, 장우익",
  "certificate": [
    {
      "cert_number": "20090105880",
      "changes": "",
      "disclosure_date": "2009-06-22",
      "first_cert_date": "2009-06-22",
      "no": "1",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2009-06-22 ~ 2011-06-21"
    },
    {
      "cert_number": "20110104665",
      "changes": "",
      "disclosure_date": "2011-07-22",
      "first_cert_date": "2009-06-22",
      "no": "2",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2011-07-22 ~ 2013-07-21"
    },
    {
      "cert_number": "20130107221",
      "changes": "",
      "disclosure_date": "2013-07-15",
      "first_cert_date": "2009-06-22",
      "no": "3",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2013-07-22 ~ 2015-07-21"
    },
    {
      "cert_number": "20150108560",
      "changes": "",
      "disclosure_date": "2015-08-18",
      "first_cert_date": "2009-06-22",
      "no": "4",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2015-07-22 ~ 2017-07-21"
    },
    {
      "cert_number": "20170109677",
      "changes": "",
      "disclosure_date": "2017-08-21",
      "first_cert_date": "2009-06-22",
      "no": "5",
      "type": "연구개발유형",
      "valid_period": "2017-07-22 ~ 2019-07-21"
    },
    {
      "cert_number": "20190109965",
      "changes": "",
      "disclosure_date": "2019-08-28",
      "first_cert_date": "2009-06-22",
      "no": "6",
      "type": "연구개발유형",
      "valid_period": "2019-07-22 ~ 2021-07-21"
    },
    {
      "cert_number": "20210826020045",
      "changes": "",
      "disclosure_date": "2021-08-26",
      "first_cert_date": "2009-06-22",
      "no": "7",
      "type": "연구개발유형",
      "valid_period": "2021-07-22 ~ 2024-07-21"
    },
    {
      "cert_number": "20240730020024",
      "changes": "",
      "disclosure_date": "2024-07-30",
      "first_cert_date": "2009-06-22",
      "no": "8",
      "type": "연구개발유형",
      "valid_period": "2024-07-22 ~ 2027-07-21"
    }
  ],
  "company_name": "주식회사 와이바이오로직스",
  "corp_no": "160111-*******",
  "financials": {
    "2022": {
      "capital_stock": 6145164000,
      "cost_of_sales": 2814101000,
      "current_assets": 18033782000,
      "current_liabilities": 16195420000,
      "gross_profit": 1336457000,
      "net_income": -18804402000,
      "net_income_bs": -18804401000,
      "non_current_assets": 11288867000,
      "non_current_liabilities": 834062000,
      "non_operating_expenses": 692764000,
      "non_operating_income": 718577000,
      "operating_profit": -18830215000,
      "revenue": 4150558000,
      "sga_expenses": 20166672000,
      "total_assets": 29322649000,
      "total_equity": 12293167000,
      "total_liabilities": 17029482000
    },
    "2023": {
      "capital_stock": 7381363000,
      "cost_of_sales": 1090103000,
      "current_assets": 21762540000,
      "current_liabilities": 5507822000,
      "gross_profit": 2388978000,
      "net_income": -20871054000,
      "net_income_bs": -20871053000,
      "non_current_assets": 8531474000,
      "non_current_liabilities": 1377731000,
      "non_operating_expenses": 11677279000,
      "non_operating_income": 948918000,
      "operating_profit": -10142693000,
      "revenue": 3479081000,
      "sga_expenses": 12531670000,
      "total_assets": 30294014000,
      "total_equity": 23408461000,
      "total_liabilities": 6885553000
    }
  },
  "industry": "의학 및 약학 연구개발업",
  "investment": [],
  "main_products": "항체의약품,항체후보물질 연구개발",
  "phone": "042-867-****",
  "years": [
    2023,
    2022
  ]
}